TTAX03

· BioTissue Holdings, Inc

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for TTAX03, covering 2025-03-07 to 2026-02-11. Get the full timeline:

Most recent: Clinical Trial Update: A Study in the Treatment of Mild to Moderate Dry Eye Disease Comparing Saline to TTAX03. [Phase 2]